Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.
Visit our Writing Guide or this topic page for additional help.
Timeline
July 27, 2012
BrainStorm Cell Therapeutics raises a $206,910 seed round.
Funding Rounds
Patents
Further Resources
Title
Author
Link
Type
Date
BrainStorm Cell Therapeutics halfCway through enrolling its Phase 3 ALS study
Christine Corrado
Web
BrainStorm Cell Therapeutics halfway through enrolling its Phase 3 ALS study
January 11, 2019
Brainstorm Cell Therapeutics updates on its progressive MS drug development trials
February 12, 2019
News
Title
Author
Date
Publisher
Description
Brainstorm Cell Therapeutics Inc
June 15, 2021
www.prnewswire.com:443
/PRNewswire/ -- Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...
Heather McKenzie
May 4, 2021
BioSpace
There is also a tacit acknowledgment in the industry that the ALSFRS-R (revised) scale needs to evolve.
Brainstorm Cell Therapeutics Inc
April 19, 2021
www.prnewswire.com:443
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today...
Nick Paul
March 24, 2021
FierceBiotech
BrainStorm Cell Therapeutics has presented phase 2 data on its stem cell therapy in patients with multiple sclerosis. The small, open-label clinical trial linked autologous therapy NurOwn to a 25% improvement in measures of mobility and dexterity in around 14% of patients.
Pomerantz LLP
March 3, 2021
www.prnewswire.com:443
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Brainstorm Cell Therapeutics Inc. ("Brainstorm" or the "Company") (NASDAQ:...
SHOW MORE
References
5
Type: Web page
https://ir.brainstorm-cell.com/stock-quote6
Type: Web page
https://cage.report/CAGE/8M4U47
Type: Web page
https://www.sec.gov/edgar/browse/?CIK=1137883&owner=exclude8
Type: Web page
https://www.sec.gov/edgar/browse/?CIK=1137883&owner=exclude9
Type: Web page
https://www.sec.gov/edgar/browse/?CIK=1137883&owner=exclude
Organization
CompanyCompany attributes
Healthcare
Biotechnology
Stem cell
Biomedical engineering
Amyotrophic lateral sclerosis
Parkinson's disease
Cell therapy
Engineering
New York City
New York
Israel
SeattleCompany Operating Status
Active
Pitchbook URL
Legal Name
Brainstorm Cell Therapeutics Inc.
Number of Employees (Ranges)
20 – 49
Full Address
1325 Avenue of Americas, 28th Floor New York City, NY 10019
Place of Incorporation
DelawareIRS Number
207,273,918
Founded Date
1992
Phone Number
+12014880460
Total Funding Amount (USD)
206,910
Latest Funding Round Date
July 27, 2012
Stock Symbol
BCLI
Exchange
NasdaqBoard of Directors
CFO
Also Known As
https://vimeo.com/brainstormcell
Latest Funding Type
Seed roundOther attributes
Contact Page URL
SIC Code
2,836
Headquarters
Country
United StatesTicker Symbol
BCLI
Categories
Related Topics
Contributors
- 1
Dawson Sewell
Writing about startups. - 2
Duzenko Andrey
Extensive experience in development and interaction with the community - 3
Patrick Pum
A crypto enthusiast since 2018 with an aviation management educational background - 4
N Ni
Nothing... - 5
Rebecca Hammond
MA English I HDip Psychology - Following AI, behavioural and educational psychology - 6
Keeri Tramm
Accomplished manager, brand communicator, and burgeoning data analyst. - 7
Erin Scherfner
loading information... - 8
Amy Sar
Data acquisition Golden, computational linguist - 9
Katrina-Kay Pettitt
Data Duchess @ Golden - 10
Kombain Mashina
why